Skip to content
OpenCapital
Get started

Danaher DHR Diagnostics — Capital expenditures, gross

Other segment segments

Biotechnology
$66M-17.5%
Life Sciences
$57M—

Similar metrics at other companies

Abbott logo
ABTDiagnostic Products — Additions to Property and Equipment
$157M-5.4%
Opko Health logo
OPKDiagnostics — Total Assets
$347.51M-27.0%
Revvity logo
RVTYDiagnostics — Depreciation
$9.56M+39.6%
Envista Holdings Corporation logo
NVSTEquipment & Consumables — Capital expenditures, gross
$3.1M-11.4%
Abbott logo
ABTDiagnostic Products — Total Assets
$9.71B+18.7%
Quest Diagnostics logo
DGXDIS business — Segment, Expenditure, Addition to Long-Lived Assets
$128.5M+25.4%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$134.62B-7.4%
Enterprise value$158.13B-1.7%
P/E33.6×-9.0×
P/S5.4×-0.7×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.

The official record: Danaher’s 10-Q, filed July 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Danaher's diagnostics — capital expenditures, gross.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Danaher's diagnostics — capital expenditures, gross?
Danaher (DHR) reported diagnostics — capital expenditures, gross of $164M in Q2 2026.
How has Danaher's diagnostics — capital expenditures, gross changed year-over-year?
Danaher's diagnostics — capital expenditures, gross increased by 31.2% year-over-year, from $125M to $164M.
What is the long-term trend for Danaher's diagnostics — capital expenditures, gross?
Over 2 years (2023 to 2025), Danaher's diagnostics — capital expenditures, gross has grown at a 4.1% compound annual growth rate (CAGR), from $546M to $592M.
What does diagnostics — capital expenditures, gross mean?
The total cash outflow for the acquisition or maintenance of physical assets, such as manufacturing machinery and laboratory equipment, within the diagnostics segment. This reflects the company's investment in future capacity and technological upgrades. It is a key indicator of long-term commitment to the segment's growth and operational modernization.